about
A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapyChimeric Glutathione S-Transferases Containing Inserts of Kininogen Peptides: POTENTIAL NOVEL PROTEIN THERAPEUTICSSuccessful identification of novel agents to control infectious diseases from screening mixture-based peptide combinatorial libraries in complex cell-based bioassays.Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens.Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.Peptide vaccines and peptidomimetics of EGFR (HER-1) ligand binding domain inhibit cancer cell growth in vitro and in vivoDoubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer's Disease Like Tau Aggregation.Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapyAlpha-crystallin-derived peptides as therapeutic chaperones.Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles.T-cell epitope-dependent immune response in inbred (C57BL/6J, SJL/J, and C3H/HeN) and transgenic P301S and Tg2576 mice.Predicting peptide vaccine candidates against H1N1 influenza virus through theoretical approaches.Generating DNA sequences encoding tandem peptide repeats suitable for expression and immunological application.
P2860
Q26824462-7CB6FC95-5415-418B-A197-8B44146C1004Q27679018-B2646A59-859A-4F42-A5C0-666166301D7BQ30937880-CA6DE0FE-EA91-44C1-92A2-4DE51E49A299Q33529578-F0487829-519E-452F-BBE1-827D37A9CC56Q34787415-C9AE84F8-888E-452D-AC5A-68AE0CF2490BQ35073267-A2C24CDC-0116-4A4F-AC37-3AF667ED1114Q35826638-7FEAEC04-49A3-4E68-B976-AAFA5738CDBCQ36116250-44349ECC-0A07-4D4D-BBC7-A54EAD72CCE8Q36355484-39F0B60D-1506-403D-BD24-F906A0754905Q37921384-2FABD803-370F-47BA-A36F-8642192236E8Q39409037-5360D448-BBEC-414C-A99A-E13DECF87C8FQ42159681-697E2203-EB41-4354-A20A-99281FB7CA2DQ54300399-998F038E-26D4-40BF-895A-7793DEBBFEF9
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Synthetic peptides as cancer vaccines.
@ast
Synthetic peptides as cancer vaccines.
@en
Synthetic peptides as cancer vaccines.
@nl
type
label
Synthetic peptides as cancer vaccines.
@ast
Synthetic peptides as cancer vaccines.
@en
Synthetic peptides as cancer vaccines.
@nl
prefLabel
Synthetic peptides as cancer vaccines.
@ast
Synthetic peptides as cancer vaccines.
@en
Synthetic peptides as cancer vaccines.
@nl
P2093
P2860
P356
P1433
P1476
Synthetic peptides as cancer vaccines.
@en
P2093
Naveen K Dakappagari
Pravin T P Kaumaya
Roshni Sundaram
P2860
P304
P356
10.1002/BIP.10258
P577
2002-01-01T00:00:00Z